Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy

Part of paid clinical trials in Tucson, Arizona.

Sponsor
SURGE Therapeutics
Study ID
NCT06450106
Phase
PHASE1
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
MALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • STM-416p — DRUG
    STM-416p monotherapy

Study Details

A Study of STM-416p Administered Intraoperatively to Patients Undergoing Radical Prostatectomy

Key Dates

Start date
May 8, 2025
Status verified
Feb 2026
Primary completion
Sep 30, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
18 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: STM-416p
    STM-416p

Primary Outcome Measure

Incidence of dose-limiting toxicities (DLTs) [Safety and Tolerability] [ Time Frame: 21 Days ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Arizona Urology SpecialistsTucsonArizona85715
Jasmine Simpson
[email protected]
Susan Kalota, MD (PRINCIPAL_INVESTIGATOR)
University of FloridaGainesvilleFlorida32608
Danielle Geckler
[email protected]
Paul Crispen, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Tucson, AZ

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
Arizona Urology Specialists· Tucson, AZUniversity of Florida· Gainesville, FL

Related Studies